A Combined Exercise and Lifestyle Intervention for Adults with Prediabetes

A 2023 secondary analysis from Duke University’s STRRIDE-PD randomised controlled trial, published in Frontiers in Physiology, provides the clearest quantification to date. The short version: exercise alone captures roughly 24–50% of the benefit that a combined prediabetes diet and exercise intervention delivers. The implications, both for individual clients and for how we structure multidisciplinary care, are worth unpacking carefully.

---

What the STRRIDE-PD Trial Actually Tested

The study enrolled 130 sedentary, overweight adults aged 45–75 with confirmed prediabetes (fasting glucose ≥95 to <126 mg/dL). Participants were randomised across four six-month supervised interventions:

Group 1 — Low-amount, moderate-intensity exercise (approximately equivalent to brisk walking three times per week)

Group 2 — High-amount, moderate-intensity exercise (roughly four sessions per week, each longer)

Group 3 — High-amount, vigorous-intensity exercise (same caloric expenditure as Group 2, but at 75% of peak VO₂)

Group 4 — A combined diet and exercise programme modelled on the landmark US Diabetes Prevention Program (DPP), targeting 7% body weight loss through dietary restriction plus the same moderate-intensity exercise as Group 1

The primary outcome was change in metabolic syndrome (MetS) z-score — a continuous composite of the five standard Adult Treatment Panel III criteria: waist circumference, triglycerides, HDL-cholesterol, blood pressure, and fasting glucose. This gave the researchers a single sensitive measure to compare across groups rather than relying solely on whether participants crossed a clinical threshold.

The Numbers: Combined Beats Exercise Alone, Clearly

The combined prediabetes diet and exercise group outperformed all three exercise-only groups, and the gap was statistically unambiguous. Participants in the combined group improved their MetS z-score by an average of 2.4 points — roughly two to four times the improvement seen in each of the exercise-only groups.

Aerobic exercise alone, across all three intensity-and-amount configurations, achieved between 24% and 50% of that combined intervention effect. The diet-and-exercise group also produced the most consistent improvements across all five individual MetS components — reducing waist circumference by an average of 5 cm, dropping triglyceride levels, lowering blood pressure, and bringing fasting glucose down significantly. The prevalence of full metabolic syndrome in that group fell from 59% at baseline to 38% after six months.

Exercise-only participants were not without gains. All three exercise groups reduced their MetS z-scores significantly from baseline, and every group improved aerobic fitness. Specific components responded well: HDL-cholesterol rose in the low-amount and high-vigorous groups, blood pressure fell in the low-moderate group, and fasting glucose came down in the high-moderate group. But no single exercise group improved all five components meaningfully, and none came close to matching the breadth of change seen when diet was included.

The Intensity Surprise: Why Pushing Harder Didn’t Help More

Perhaps the most counterintuitive finding in the STRRIDE-PD analysis concerns exercise intensity. Across the MetS z-score and most of its components, the low-amount moderate-intensity group performed as well as or quantitatively better than the high-amount vigorous-intensity group — despite expending considerably fewer calories and exercising for shorter total durations.

This mirrors earlier findings from STRRIDE I, in which moderate-intensity exercise significantly improved MetS z-score while the same amount of vigorous exercise did not. The researchers note that moderate-intensity exercise appears to have particular advantages for insulin sensitivity, a finding consistent with prior mechanistic work from the same group.

The clinical upshot is meaningful: for clients with prediabetes managing comorbidities, joint pain, or simply low exercise tolerance, there is strong evidence that a sustainable moderate-intensity routine — three sessions per week, each around 150–160 minutes collectively — is not a compromise. It may actually be the appropriate prescription.

This is exactly the kind of evidence that shapes personalised exercise therapy when working with older adults or those navigating metabolic risk. The goal is not to maximise intensity; it is to find the minimum effective dose that can be sustained, and then to layer in the dietary changes that unlock the remaining benefit.

Where Diet Does the Work Exercise Cannot

The combined group’s dietary component was a supervised programme aiming for 7% body weight reduction over six months — roughly 0.6 kg per week — achieved through caloric restriction and a low-fat diet. It worked. The diet-and-exercise group lost an average of 6.4 kg across the intervention period. The highest-performing exercise-only group lost just over 2 kg.

That weight differential explains much of the gap in triglyceride reduction, waist circumference change, and fasting glucose improvement. Some components of metabolic syndrome — particularly visceral adiposity and triglycerides — respond more robustly to energy deficit than to exercise volume alone. Exercise is a powerful tool for improving insulin sensitivity and cardiorespiratory fitness, but it is not particularly efficient at creating the caloric deficit required to shift body composition meaningfully in a six-month window.

This does not diminish the role of exercise — it clarifies it. Both modalities are working through partially distinct mechanisms, which is precisely why they outperform each other in combination.

The STRRIDE-PD findings reinforce what a well-structured dietetics input looks like in practice: not generic healthy-eating advice, but a targeted, supervised plan with a defined weight-reduction objective, delivered alongside the exercise prescription rather than as an afterthought.

For Clients and Families: What This Means Practically

For someone diagnosed with prediabetes, the question is rarely “should I exercise or change my diet?” The evidence strongly suggests the answer to both must be yes. But the study also offers reassurance: exercise alone is far from futile. Achieving half the benefit of a gold-standard diabetes prevention programme through brisk walking alone is a clinically meaningful result, and it is a reasonable starting point for clients who are not yet ready — or able — to undertake a full dietary intervention simultaneously.

The Futureproof active seniors programme provides structured, therapist-supervised exercise designed specifically for older adults managing chronic conditions, including metabolic risk, in a home or community setting. Progressions are calibrated to the individual rather than a generic group template — which maps directly onto what the STRRIDE-PD data suggests: that a modest, consistent moderate-intensity routine, right-sized for the person in front of you, is where sustainable metabolic benefit begins.

A Note on Individualisation

The study’s authors flag that individuals varied considerably in their responses to each intervention. Some exercise-only participants saw outsized improvements in specific MetS components; others responded minimally. This individual heterogeneity is a reminder that population-level findings inform prescriptions but do not determine them. When metabolic syndrome is the target, the case for periodic reassessment — adjusting both exercise and dietary components over time based on measured outcomes — is strong.

Frequently Asked Questions

Can prediabetes be reversed with exercise alone? Exercise alone produces meaningful improvements in metabolic syndrome — the cluster of risk factors most strongly associated with progression to type 2 diabetes. However, the STRRIDE-PD trial found that exercise without dietary change captures only 24–50% of the benefit of a combined programme. Reversal is more reliably achieved when both are pursued together.

How much exercise is needed for prediabetes management? The STRRIDE-PD trial found that a low-to-moderate amount of moderate-intensity exercise — roughly three sessions per week totalling around 150–160 minutes — produced improvements in metabolic syndrome comparable to higher-volume or higher-intensity protocols. Consistency and sustainability appear to matter more than intensity.

Does the type of exercise matter for metabolic syndrome? This trial focused on aerobic exercise. Within that category, moderate intensity (equivalent to brisk walking or easy cycling) produced results equal to or better than vigorous intensity for overall metabolic syndrome score. For individual components such as triglycerides and HDL-cholesterol, there were some intensity-specific effects, suggesting that for certain risk markers, the prescription may need to be tailored to the target.

Why is diet important alongside exercise for prediabetes? Exercise and dietary restriction work through partially distinct mechanisms. Exercise improves insulin sensitivity and cardiorespiratory fitness but is not efficient at producing the caloric deficit required for substantial weight reduction. Dietary intervention directly addresses visceral adiposity and triglyceride levels — components of metabolic syndrome that are particularly weight-sensitive. Together, they address a broader range of risk factors than either alone.

Is vigorous exercise better than moderate exercise for diabetes prevention? Based on the STRRIDE-PD trial, the answer is no — at least not for overall metabolic syndrome score. The low-amount moderate-intensity group performed at least as well as the high-amount vigorous group. For people with prediabetes managing joint issues or low exercise capacity, this is clinically important: there is no need to push into vigorous intensity to achieve meaningful metabolic benefit.